Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS

FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.

More from Archive

More from Pink Sheet